A novel break point of the BMPR2 gene exonic deletion in a patient with pulmonary arterial hypertension

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

The presence of genetic rearrangements of bone morphogenetic protein type 2 receptor (BMPR2) was identified in pulmonary arterial hypertension (PAH) patients as the deletion or duplication of one or more exons of the gene. We recently investigated the deletion break points in exonic deletions of BMPR2 in two Japanese familial cases with PAH, and found that these were Alu-mediated via either non-allelic homologous recombination or non-homologous recombination. We herein report the third case of exonic deletion, which was in a 25-year-old female PAH patient with a deletion of BMPR2 exon 3. The break point in this case was not located in an Alu sequence. The 5′- and 3′-break point maps between the inverted Alu sequences in intron 2 and in exon 3, respectively, resulted in a 759-bp deletion. This novel exonic deletion in this PAH case may be a unique and non-recurrent rearrangement, and appears to be of a different size from that in other patients. © 2013 The Japan Society of Human Genetics All rights reserved 1434-5161/13.

Cite

CITATION STYLE

APA

Aimi, Y., Hirayama, T., Kataoka, M., Momose, Y., Nishimaki, S., Matsushita, K., … Gamou, S. (2013). A novel break point of the BMPR2 gene exonic deletion in a patient with pulmonary arterial hypertension. Journal of Human Genetics, 58(12), 815–818. https://doi.org/10.1038/jhg.2013.100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free